SCHEMBL6955296

SCHEMBL6955296

Nc1cccc2c1COCO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.39
CD44 P16070 1/20 0.32
TSHR P16473 3/20 0.31
PKM P14618 1/20 0.31
CHRNB4 P30926 2/20 0.31
CHRNA3 P32297 2/20 0.31
LMNA P02545 2/20 0.31
CRHBP P24387 2/20 0.31
CRHR2 Q13324 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNA4 P43681 1/20 0.31
HTT P42858 1/20 0.31
ALDH1A1 P00352 2/20 0.31
CYP3A4 P08684 2/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CYP19A1 P11511 1/20 0.31
GID4 Q8IVV7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29361235 1.00 ABCG2 (0.39) ABCG2CD44TSHRPKMCHRNB4
SCHEMBL7394171 0.77 PNMT (0.40) ABCG2
SCHEMBL30874548 0.77 PNMT (0.40) ABCG2
SCHEMBL31634143 0.76 ABCG2 (0.39) ABCG2TSHRPKMLMNACRHBP
SCHEMBL6928146 0.76 ABCG2 (0.39) ABCG2TSHRPKMLMNACRHBP
SCHEMBL12043582 0.76 MAP3K14 (0.41) ABCG2TSHRPKMLMNACRHBP
SCHEMBL7481318 0.76 ABCG2 (0.39) ABCG2TSHRPKMLMNAALDH1A1
SCHEMBL1172294 0.75 CYP3A4 (0.33) CD44TSHRSMN1; SMN2ALDH1A1CYP3A4
SCHEMBL23668349 0.73 ABCG2 (0.37) ABCG2ALDH1A1
SCHEMBL19500892 0.73 GABRA1 (0.38) ABCG2TSHRPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552029-B1 For therapy of rheumatoid arthritis, psoriasis, graft v. host disease, asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis, complications following percutaneous transluminal coronary angioplasty, thrombosis CELLTECH R&D LIMITED (GB) 2003-04-22 US disclosed
EP-0934304-B1 2-PYRIMIDINEAMINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION CELLTECH THERAPEUTICS LTD (GB) 2003-02-26 EP disclosed
US-6114333-A 2-Pyrimidineamine derivatives and processes for their preparation CELLTECH THERAPEUTICS LTD. (GB) 2000-09-05 US disclosed